Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arteris, Inc.AIP · Entity 2399 | Director | August 03, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arteris, Inc.
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012 | 64,079 |
Reported balance
After 2026-08-03 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-08-03 · Sale · Disposed 5,921 · Balance 64,079 F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.11 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012 | 27,252 |
Reported balance
After 2026-08-03 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-03 · Sale · Disposed 36,827 · Balance 27,252 F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025. F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.17 to $30.16 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | IndirectBy Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust dtd 11/26/2012 | 0 |
Reported balance
After 2026-08-03 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-08-03 · Sale · Disposed 27,252 · Balance 0 F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025. F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.17 to $30.61 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 4,703 |
Reported balance
Holding disclosure · report date 2026-08-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 4,703 |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on November 7, 2025.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.17 to $29.11 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The shares are held by Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the Reporting Person serves as trustee.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.17 to $30.16 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.17 to $30.61 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2023 Filed Jun 8, 2023 21:06 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 29,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004986 · primarydocument.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,054 F1 · shares: Includes 29,027 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. Read SEC document |
| April 20, 2023 Filed Apr 24, 2023 20:55 UTC | Arteris, Inc. AIP · Entity 2399 | Exercise / conversionCommon Stock · Derivative | 8,334 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001562180-23-003665 · primarydocument.xml · derivative · entry 3 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,083 Underlying: Common Stock · 8,334 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the stock option will vest and become exercisable in 36 substantially equal installments commencing on May 23, 2020. Read SEC document |
| April 20, 2023 Filed Apr 24, 2023 20:55 UTC | Arteris, Inc. AIP · Entity 2399 | Exercise / conversionCommon Stock | 8,334 | $0.60 | $5,000.40 |
DisclosureSEC source: 0001562180-23-003665 · primarydocument.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares subject to the stock option will vest and become exercisable in 36 substantially equal installments commencing on May 23, 2020. Read SEC document |
| April 05, 2023 Filed Apr 7, 2023 18:56 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 3,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003492 · primarydocument.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,693 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:02 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 3,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-000305 · primarydocument.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,467 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 00:03 UTC | Arteris, Inc. AIP · Entity 2399 | Exercise / conversionCommon Stock · Derivative | 27,083 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001562180-22-008373 · primarydocument.xml · derivative · entry 3 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,417 Underlying: Common Stock · 27,083 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the stock option will vest and become exercisable in 36 substantially equal installments commencing on May 23, 2020. Read SEC document |
| December 15, 2022 Filed Dec 20, 2022 00:03 UTC | Arteris, Inc. AIP · Entity 2399 | Exercise / conversionCommon Stock | 27,083 | $0.60 | $16,249.80 |
DisclosureSEC source: 0001562180-22-008373 · primarydocument.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares subject to the stock option will vest and become exercisable in 36 substantially equal installments commencing on May 23, 2020. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:09 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 2,175 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-018360 · doc1.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,914 F1 · shares: Fully vested restricted stock. The restricted stock represent retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. Read SEC document |
| July 20, 2022 Filed Jun 26, 2023 22:51 UTC | Arteris, Inc. AIP · Entity 2399 | GiftCommon Stock | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005505 · primarydocument.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,304 F1 · shares: The shares are transferred to Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust for which the reporting person is the trustee. Read SEC document |
| July 05, 2022 Filed Aug 3, 2022 21:27 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 1,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014891 · doc1.xml · nonDerivative · entry 2 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,739 F1 · shares: Fully vested restricted stock. The restricted stock represent retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 22:09 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 16,464 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-013008 · doc1.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,714 F1 · shares: Represents restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. Read SEC document |
| April 05, 2022 Filed Aug 3, 2022 21:27 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 1,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014891 · doc1.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,847 F1 · shares: Fully vested restricted stock. The restricted stock represent retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. Read SEC document |
| November 12, 2021 Filed Nov 23, 2022 21:13 UTC | Arteris, Inc. AIP · Entity 2399 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,833 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001567619-22-020845 · doc1.xml · derivative · entry 3 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 20,833 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the stock option will vest and become exercisable in 36 substantially equal installments commencing on May 23, 2020. Read SEC document |
| November 12, 2021 Filed Nov 23, 2022 21:13 UTC | Arteris, Inc. AIP · Entity 2399 | Exercise / conversionCommon Stock | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-020845 · doc1.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares subject to the stock option will vest and become exercisable in 36 substantially equal installments commencing on May 23, 2020. Read SEC document |
| October 26, 2021 Filed Oct 30, 2021 00:36 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019037 · doc1.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F1 · shares: Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 6,250 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.